IDIBAPS-Hospital Clínic, the University of Barcelona (UB) and CIBERER are promoting this new advance to fight against a genetic and minority disease1
Research based on eight cohorts from Europe and Australia, provides new guidelines for assessing and monitoring lung health throughout life.
A study published in the journal Nature and coordinated by the Sainsbury Wellcome Centre in London, with the participation of the IDIBAPS-Hospital Cl1
A retrospective study conducted at IDIBAPS-Hospital Clínic suggests that many anaesthetic drugs previously considered risky could be safe in patients1
The new Cellometer™ Ascend™ (Revvity) device is a counter that is characterised, among other features, by an automated analysis that provides informa1
Hepatic stellate cells are responsible for producing fibrosis in the liver. Under normal conditions, these cells remain dormant, but when liver tissu1
IDIBAPS has published its Action Plan to implement the principles of the Coalition for Advancing Research Assessment (CoARA), thereby upholding its c1
